These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 13265830)

  • 1. Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives.
    CERLETTI A; ROTHLIN E
    Nature; 1955 Oct; 176(4486):785-6. PubMed ID: 13265830
    [No Abstract]   [Full Text] [Related]  

  • 2. The antagonism between 5-hydroxytryptamine and certain derivatives of lysergic acid.
    SAVINI EC
    Br J Pharmacol Chemother; 1956 Sep; 11(3):313-7. PubMed ID: 13364207
    [No Abstract]   [Full Text] [Related]  

  • 3. Antagonism between lysergic acid diethylamide and 5-hydroxytryptamine.
    GADDUM JH
    J Physiol; 1953 Jul; 121(1):15P. PubMed ID: 13085323
    [No Abstract]   [Full Text] [Related]  

  • 4. [Contribution to the psychopathological study of the effects of lysergic acid monoethylamide].
    CALLIERI B; RAVETTA M
    Arch Psicol Neurol Psichiatr; 1956; 17(1):43-79. PubMed ID: 13341385
    [No Abstract]   [Full Text] [Related]  

  • 5. Brom-lysergic acid diethylamide: a highly potent serotonin antagonist.
    SOLLERO L; PAGE IH; SALMOIRAGHI GC
    J Pharmacol Exp Ther; 1956 May; 117(1):10-5. PubMed ID: 13320295
    [No Abstract]   [Full Text] [Related]  

  • 6. [First trials of psychopharmacological antagonism; experimental psychoses induced with d-lysergic acid diethylamide and treated with chlorpromazine and reserpine].
    GIBERTI F; GREGORETTI L
    Sist Nerv; 1955; 7(4):301-10. PubMed ID: 13290891
    [No Abstract]   [Full Text] [Related]  

  • 7. [Specific inhibition of serotonin effects by lysergic acid diethylamide and similar compounds].
    CERLETTI A; KONZETT H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1956; 228(1-2):146-8. PubMed ID: 13334586
    [No Abstract]   [Full Text] [Related]  

  • 8. [Etiology of psychoses of the acute, exogenous reaction type; diethylamide of lysergic acid, a toxic trace element with psychic effects].
    BLICKENSTORFER E
    Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr; 1952; 188(3):226-36. PubMed ID: 12977367
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the inhibition of various rat paw edemas by serotonin antagonists].
    VOGEL G; MAREK ML
    Arzneimittelforschung; 1961 Nov; 11():1051-4. PubMed ID: 13926418
    [No Abstract]   [Full Text] [Related]  

  • 10. The serotonin antagonist 1-methyl-D-lysergic acid butanolamine (UML-491) or methysergide ('Deseril'), its pharmacodynamics and effects on 'migraine type' vascular headaches.
    LEIGH WE
    S Afr Med J; 1963 Jun; 37():631-7. PubMed ID: 13929429
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antagonistic effect of diethylamide of lysergic acid and of methylamphetamine on experimental catalepsy caused by 5-hydroxytryptamine; experimental research on dogs].
    GARELLO L; DOLCE G
    Sist Nerv; 1956; 8(2):61-80. PubMed ID: 13351829
    [No Abstract]   [Full Text] [Related]  

  • 12. Diethylamine of lysergic acid and its reaction to 5-hydroxytryptamine catalepsy in dog.
    SACCHI U; BONAMINI F; DOLCE G; GARELLO L
    Boll Soc Ital Biol Sper; 1955 Jun; 31(6):665-7. PubMed ID: 13269564
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lysergic acid monoethylamide, a new ergot derivatives with sedative effect in psychiatric medication].
    SOLMS H
    Schweiz Arch Neurol Psychiatr; 1954; 73(1-2):440-4. PubMed ID: 13195594
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lysergic acid ethylamide, a new ergot drug strongly sedative effect causing psychotic states].
    SOLMS H
    Schweiz Med Wochenschr; 1953 Apr; 83(15):356-60. PubMed ID: 13076048
    [No Abstract]   [Full Text] [Related]  

  • 15. [Psychological effects of lysergic acid monoethylamide (LAE 32)].
    TONINI G; MONTANARI C
    G Psichiatr Neuropatol; 1955; 83(2):355-7. PubMed ID: 13251531
    [No Abstract]   [Full Text] [Related]  

  • 16. [D-lysergic acid diethylamine and psychic disorders in ergotism].
    DELAY J; PICHOT P
    C R Seances Soc Biol Fil; 1951 Nov; 145(21-22):1609-10. PubMed ID: 14926207
    [No Abstract]   [Full Text] [Related]  

  • 17. Yohimbine and ergot alkaloids as naturally occurring antimetabolites of serotonin.
    SHAW E; WOOLLEY DW
    J Biol Chem; 1953 Aug; 203(2):979-89. PubMed ID: 13084668
    [No Abstract]   [Full Text] [Related]  

  • 18. [Electrical rhythms of the brain following administration of mescaline and lysergic acid (LSD 25) in mental disorders].
    SANGUINETI I; NEGRI VU; LARICCHIA R
    Riv Sper Freniatr Med Leg Alien Ment; 1955 Dec; 79(4):771-97. PubMed ID: 13311367
    [No Abstract]   [Full Text] [Related]  

  • 19. Ergot alkaloids: synthetic approaches to lysergic acid and clavine alkaloids.
    Liu H; Jia Y
    Nat Prod Rep; 2017 Apr; 34(4):411-432. PubMed ID: 28300233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serotonin-producing tumors. A case treated with serotonin antagonists].
    JENSEN K
    Nord Med; 1963 May; 69():601-5. PubMed ID: 13957630
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.